SGO Annual Mtg 2023: Miscellaneous topics

This post completes my coverage of the 2023 SGO Annual Meeting. Below are some tweets on  miscellaneous topics from treatments to testing.

 Cryocompression

Prevention of neuropathy in gyn cancer patients. 

The data are in! Cryocompression therapy works during chemo and prevents subjective neuropathy in patients with gyn cancers. Congrats @MKMontesDeOca @LHavrilesky and @dukeobgyn team. #SGOMtg #PatientsPurposeProgress pic.twitter.com/VU6p3JYvMG

— Rebecca Previs (@BeccaPrevisMD) March 25, 2023

 Immune Biomarkers in Locally Advanced Cervical Cancer 

Combo of durvalumab concurrent with radiation produce more tumor-associated T-cells clones. 

Zamarin presenting LACC Evolution of peripheral and tumor immune parameters as biomarkers of differential sequencing of immune checkpoint blockade and chemoradiotherapy in locally advanced cervical cancer: An NRG Oncology/GOG Study #SGOMtg #gyncsm pic.twitter.com/ky1yWh3jjd

— Dee Sparacio (@womenofteal) March 25, 2023

Palliative Care  

Higher value and less aggressive care at end of life with early palliative care.

Impact of Timing of Palliative Care
Initiation on End-of-Life Quality Metrics
and Health Resource Utilization ,Mah #SGOmtg, #gyncsm Early palliative care is assoc w/ higher-value and less aggressive end-of-life care#palliativecare pic.twitter.com/mpPKFZY9ig

— Dee Sparacio (@womenofteal) March 28, 2023

Palliative care referral was impacted by diagnosis and insurance coverage. 

Palliative Care Utilization of Gynecology Oncology Patients with Advanced Cancer #SGOMtg #gyncsm Disparities in palliative care referral based on cancer
diagnosis/insurance were significant,No significant difference in referrals
based on age, race/ethnicity or preferred language pic.twitter.com/11D2SXbxqo

— Dee Sparacio (@womenofteal) March 28, 2023

Breast MRI 

Denials in women with hereditary BRCA1/2 mutations with gyn cancer diagnosis.

Barriers to early detection: Breast MRI denials in patients with
germline BRCA1/2 mutations Gordhandas, #SGOmtg #gyncsm #bcsm #patientspurposeprogress increase time to rec MRI, collaborate w/insurers pic.twitter.com/WfEhy7VwTX

— Dee Sparacio (@womenofteal) March 28, 2023

Funding gaps  

Significant gaps in funding for gyn cancers compared to other cancer types

Significant funding gaps exist for lethal gynecologic cancers compared to other malignancies. We all need to advocate with Congress for more funding! Highlighted by Dr Victor Dzau #NAM during Presidential Lecture at #sgomtg ⁦@uppals⁩ ⁦@SGO_org⁩ pic.twitter.com/gV4AiRB6wl

— Joshua Garrett Cohen (@JCohenMD) March 25, 2023

Obesity  

Japanese study showed obese women have higher risk of uterine cancer

The Consequence of Obesity on the Risk of Uterine Cancer Incidence in Younger vs. Older Adults Stewart #SGOMtg #gyncsm Taiwan data | Obese and overweight patients have a higher risk of uterine cancer pic.twitter.com/473v6Lpu6m

— Dee Sparacio (@womenofteal) March 28, 2023

HPV vaccination

Intervention helps uptake of HPV in clinic 

Every nudge counts: Impact of a clinical intervention bundle on the uptake of HPV vaccination in an under-resourced clinic
Byrne #SGOmtg #gyncsm pic.twitter.com/pkJ5RVWGqW

— Dee Sparacio (@womenofteal) March 28, 2023

 Tremelimumab, durvalumab, and radiotherapy

Patients with cervical or vaginal cancers had good overall response rates if high in PDL1

#SGOMtg #gyncsm
A phase I study of tremelimumab, durvalumab, and hypofractionated radiotherapy for metastatic gynecologic cancers
Lin , 18 patients cervical and vaginal, ORR in PDL1 high patients pic.twitter.com/IMqBpQZOFI

— Dee Sparacio (@womenofteal) March 27, 2023

In June I will report on  research of interest presented at the ASCO annual meeting which I will attend virtually. 

Dee

Every Day is a Blessing!